Targeted Metabolic Profiling of Urine Highlights a Potential Biomarker Panel for the Diagnosis of Alzheimer’s Disease and Mild Cognitive Impairment: A Pilot Study

The lack of sensitive and specific biomarkers for the early detection of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) is a major hurdle to improving patient management. A targeted, quantitative metabolomics approach using both (1)H NMR and mass spectrometry was employed to investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yilmaz, Ali, Ugur, Zafer, Bisgin, Halil, Akyol, Sumeyya, Bahado-Singh, Ray, Wilson, George, Imam, Khaled, Maddens, Michael E., Graham, Stewart F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569858/
https://www.ncbi.nlm.nih.gov/pubmed/32878308
http://dx.doi.org/10.3390/metabo10090357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569858/
https://www.ncbi.nlm.nih.gov/pubmed/32878308
http://dx.doi.org/10.3390/metabo10090357

Ejemplares similares